BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 35999621)

  • 21. Research progress concerning m
    Zhou Y; Yang J; Tian Z; Zeng J; Shen W
    Oncol Lett; 2021 Nov; 22(5):775. PubMed ID: 34589154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging function of N6-methyladenosine in cancer.
    Hong K
    Oncol Lett; 2018 Nov; 16(5):5519-5524. PubMed ID: 30344705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of N6-methyladenosine with viruses and related diseases.
    Wu F; Cheng W; Zhao F; Tang M; Diao Y; Xu R
    Virol J; 2019 Nov; 16(1):133. PubMed ID: 31711514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
    Meng Q; Schatten H; Zhou Q; Chen J
    Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
    Kumari R; Ranjan P; Suleiman ZG; Goswami SK; Li J; Prasad R; Verma SK
    Cardiovasc Res; 2022 Jun; 118(7):1680-1692. PubMed ID: 33956076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of m6A RNA modification in cancer therapeutic resistance.
    Liu WW; Zhang ZY; Wang F; Wang H
    Exp Hematol Oncol; 2023 Feb; 12(1):21. PubMed ID: 36810281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.
    Ma W; Wu T
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1190-C1205. PubMed ID: 36036444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential roles of RNA N6-methyladenosine in atherosclerosis.
    Chen LH; Zhao YY; Huang L; Li YZ; Xu HQ; Yang C; Zhang C
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1075-1083. PubMed ID: 35253196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of regulators of RNA m
    Zhang Q; Xu K
    Genes Dis; 2023 Mar; 10(2):495-504. PubMed ID: 37223516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors.
    Liu S; Lao Y; Wang Y; Li R; Fang X; Wang Y; Gao X; Dong Z
    Front Cell Dev Biol; 2021; 9():676364. PubMed ID: 34124065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-methyladenosine modification: A potential regulatory mechanism in spinal cord injury.
    Liu D; Fan B; Li J; Sun T; Ma J; Zhou X; Feng S
    Front Cell Neurosci; 2022; 16():989637. PubMed ID: 36212687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
    Jayasree PJ; Dutta S; Karemore P; Khandelia P
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
    He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
    Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
    Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
    Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA m
    Wang P; Feng M; Han G; Yin R; Li Y; Yao S; Lu P; Wang Y; Zhang H
    Front Cell Dev Biol; 2021; 9():710964. PubMed ID: 34485297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.